Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities

Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are a frequent class of driver mutations. Single EGFR tyrosine kinase inhibitor (TKI) provides substantial clinical benefit, but almost nil radiographic complete responses. Patients invariably progress, although survival can re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosell, Rafael, Cardona, Andrés Felipe, Arrieta, Oscar, Aguilar, Andrés, Ito, Masaoki, Pedraz, Carlos, Codony-Servat, Jordi, Santarpia, Mariacarmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351231/
https://www.ncbi.nlm.nih.gov/pubmed/34373568
http://dx.doi.org/10.1038/s41416-021-01519-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351231/
https://www.ncbi.nlm.nih.gov/pubmed/34373568
http://dx.doi.org/10.1038/s41416-021-01519-2

Ejemplares similares